Lyme Disease Support 1

ALUMEN, CALCAREA CARBONICA, DNA, FERRUM PHOSPHORICUM, HEPAR SULPHURIS CALCAREUM, KALI CARBONICUM, KALI MURIATICUM, KALI SULPHURICUM, MAGNESIA PHOSPHORICA, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, RNA, SILICEA. ORAL HUMAN OTC DRUG

Lyme Disease Support 1 is an FDA drug label for the active ingredient ALUMEN, CALCAREA CARBONICA, DNA, FERRUM PHOSPHORICUM, HEPAR SULPHURIS CALCAREUM, KALI CARBONICUM, KALI MURIATICUM, KALI SULPHURICUM, MAGNESIA PHOSPHORICA, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, RNA, SILICEA. manufactured by OHM PHARMA INC. administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20211229.

Generic name
ALUMEN, CALCAREA CARBONICA, DNA, FERRUM PHOSPHORICUM, HEPAR SULPHURIS CALCAREUM, KALI CARBONICUM, KALI MURIATICUM, KALI SULPHURICUM, MAGNESIA PHOSPHORICA, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, RNA, SILICEA.
Manufacturer
OHM PHARMA INC.
Product type
HUMAN OTC DRUG
Route
ORAL
Dosage form
N/A
NDC
66096-722
Application
N/A
Label effective
20211229

Active ingredients

ACTIVE INGREDIENTS: Equal amounts of: Alumen 12X, Calcarea carbonica 6X, DNA 4C, Ferrum phosphoricum 6X, Hepar sulphuris calcareum 6X, Kali carbonicum 6X, Kali muriaticum 6X, Kali sulphuricum 6X, Magnesia phosphorica 6X, Natrum muriaticum 6X, Natrum phosphoricum 6X, RNA 4C, Silicea 12X.

Indications & Usage

USES: Supports the immune systems response to Lyme disease symptoms.* * ​Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Dosage & Administration

DIRECTIONS: Shake bottle 10 times prior to each use. Adults & children above 12 years of age: Take 10 drops under the tongue 3 times per day or as directed by a health care practioner. Children under 12: Consult a health care provider.

Contraindications

Not available.

Warnings

WARNINGS: iF PREGNANT OR BREAST-FEEDING, ask a health care professional before use. If symptoms worsen or persist for more than a week, discontinue use and contact a doctor. ​KEEP OUT OF REACH OF CHILDREN.

Adverse Reactions

Not available.